Cold Oxygenated Rapid Recovery in Heart Donation After Circulatory Death [0.03%]
循环死亡供心捐献中冷氧合快速复苏的临床应用
Elizabeth J Bashian,Thomas F O&#x;Shea,David N Campbell et al.
Elizabeth J Bashian et al.
Sadiya S Khan
Sadiya S Khan
Raef A Fadel,Herbert D Aronow
Raef A Fadel
Does Characterization of Phenotypic Heterogeneity Provide Mechanistic Insights or Influence the Response to Treatment? Experience in Positive and Neutral Trials in Patients With Heart Failure and a Preserved Ejection Fraction [0.03%]
表型异质性的特征描述能提供机制见解或影响治疗反应吗？来自心力衰竭射血分数保留的阳性试验和阴性试验的经验
Milton Packer,Gabriele G Schiattarella,Mark C Petrie et al.
Milton Packer et al.
At a time when there was no unifying hypothesis and no broadly effective treatments for heart failure with a preserved ejection fraction (HFpEF), it was proposed that HFpEF represented a multitude of different disorders. Accordingly, charac...
Loss of ATP-Dependent Citrate Lyase Drives Left Ventricular Dysfunction by Metabolic Remodeling [0.03%]
丙酮酸脱氢酶丧失通过代谢重塑导致左心室功能障碍
Shijie Liu,Seth T Gammon,Lin Tan et al.
Shijie Liu et al.
Background: Metabolic adaptation and maladaptation are hallmarks of the failing heart and may be a target for therapeutic interventions. For example, sustained glucose oxidation during cardiac stress is associated with in...
Caffeine and Cardiovascular Disease: A Scientific Statement From the American Heart Association [0.03%]
咖啡因与心血管病：美国心脏协会科学声明
Gregory M Marcus,Frank B Hu,Rob M van Dam et al.
Gregory M Marcus et al.
Caffeine is one of the most commonly consumed drugs in the world. It is found in various naturally occurring substances and can be ingested in a synthetically derived pure form. The majority of human subject-based research is observational ...
Correction to: 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/ SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines [0.03%]
急性肺栓塞成年人的评估和管理：美国心脏病学会/美国心脏协会联合临床实践指南小组报告的更正（2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN指南）
Mark A Creager,Geoffrey D Barnes,Jay Giri et al.
Mark A Creager et al.
Published Erratum
Circulation. 2026 Jul 14;154(2):e24. DOI:10.1161/CIR.0000000000001462 2026
Transforming Pulmonary Arterial Hypertension: Key Milestones and Future Perspectives [0.03%]
肺动脉高压的治疗变迁：关键里程碑与未来展望
Marc Humbert,Katarina Zeder,Gabor Kovacs et al.
Marc Humbert et al.
Pulmonary arterial hypertension (PAH) is a rare, progressive disease of the precapillary pulmonary arteries, characterized by fibroproliferative vascular remodeling, increased pulmonary vascular resistance, right ventricular failure, and pr...
Yiannis Fragkoulis,Konstantinos I Karampinos,Ilias Karabinos
Yiannis Fragkoulis
Letter by Astan et al Regarding Article, "The Role of the Collateral Circulation in Stable Angina: An Invasive Placebo-Controlled Study" [0.03%]
Astan等关于《稳定型心绞痛血管旁路的的作用：一项侵入性安慰剂对照研究》的文章来信
Ramazan Astan,Fehmi Kaçmaz,Ersin Sariçam
Ramazan Astan